Paul Sanghera

University Hospitals Birmingham NHS Foundation Trust — United Kingdom

Medicine · Health Sciences

28h-index2.6kcitations273works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(69), Glioma Diagnosis and Treatment(56), Brain Metastases and Treatment(39), Advanced Radiotherapy Techniques(33), RFID technology advancements(27)

Publications273 total

P09.16.A TREATMENT OF BRAIN RADIONECROSIS: A SURVEY OF PROVISION OF CARE AND ACCESS TO BEVACIZUMAB IN THE UNITED KINGDOM
Neuro-Oncology·2025Open Access
PATIENTS’ EXPERIENCE OF THE NEURO-ONCOLOGY JOURNEY: INTERIM ANALYSIS OF A SINGLE-CENTRE EVALUATION AND RECOMMENDATIONS
Neuro-Oncology·2025Open Access
1317O Results from CompARE phase III RCT: Neoadjuvant durvalumab plus chemoradiotherapy (CRT) followed by adjuvant durvalumab immunotherapy (IO) vs CRT alone in intermediate and high-risk oropharyngeal cancer (OPC)
Annals of Oncology·2025· 1 cited
Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation
Neuro-Oncology·2025· 3 citedOpen Access
Calculating optic nerve planning organ at risk volume margins for stereotactic radiosurgery using optic nerve motion determined using MRI: Response to Letter
British Journal of Radiology·2025
1386 Impact of the introduction of “5+5” contouring on efficacy and swallowing outcomes in the phase 3 randomised CompARE trial.
Radiotherapy and Oncology·2025
Hypo-Fractionated Radiotherapy to the Cavity for Resected Brain Metastases: A UK Series
Clinical Oncology·2025
Outcomes of Patients With Five or More Brain Metastases Treated With Stereotactic Radiosurgery From 2014 to 2019: A UK Series
Clinical Oncology·2024Open Access
QOL-14. HEALTH-RELATED QUALITY OF LIFE AND COGNITIVE FUNCTIONING IN SURVIVORS OF OLIGODENDROGLIOMA: AN INTERNATIONAL CROSS-SECTIONAL INVESTIGATION
Neuro-Oncology·2024Open Access
Calculating optic nerve planning organ at risk volume margins for stereotactic radiosurgery using optic nerve motion determined using MRI
British Journal of Radiology·2024· 2 citedOpen Access
KS04.7.A HEALTH-RELATED QUALITY OF LIFE AND COGNITIVE FUNCTIONING IN SURVIVORS OF OLIGODENDROGLIOMA: AN INTERNATIONAL CROSS-SECTIONAL INVESTIGATION
Neuro-Oncology·2024Open Access
P17.02.B BMSCOPE: A SCOPING REVIEW TO CHART THE EVOLVING CLINICAL STUDY LANDSCAPE IN BRAIN AND LEPTOMENINGEAL METASTASIS
Neuro-Oncology·2024Open Access
BMScope: A scoping review to chart the evolving clinical study landscape in brain and leptomeningeal metastasis
Neuro-Oncology·2024· 3 citedOpen Access
A Randomised Phase II Trial of Hippocampal Sparing Versus Conventional Whole Brain Radiotherapy After Surgical Resection or Radiosurgery in Favourable Prognosis Patients With 1–10 Brain Metastases
Clinical Oncology·2024· 2 citedOpen Access
The Utility of Multiparametric Magnetic Resonance Imaging in Reducing Diagnostic Uncertainty for Primary Central Nervous System Lymphoma
World Neurosurgery·2024· 2 cited
CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer
Trials·2024· 16 citedOpen Access
Beyond T2-FLAIR mismatch sign in isocitrate dehydrogenase mutant 1p19q non-codeleted astrocytoma: Analysis of tumor core and evolution with multiparametric magnetic resonance imaging
Neuro-Oncology Advances·2024Open Access
REVIEW OF THE INTRODUCTION OF WHOLE GENOME SEQUENCING AS NHS STANDARD OF CARE FOR BRAIN TUMOUR PATIENTS AT QUEEN ELIZABETH HOSPITAL BIRMINGHAM, UK
Neuro-Oncology·2023Open Access
INCIDENCE AND PREDICTORS OF CLINICALLY SIGNIfiCANT ACUTE AND LATE TREATMENT-RELATED TOXICITY AFTER STEREOTACTIC RADIOSURGERY IN 4 OR MORE BRAIN METASTASES
Neuro-Oncology·2023Open Access
Radiation treatment of benign tumors in NF2-related-schwannomatosis: A national study of 266 irradiated patients showing a significant increase in malignancy/malignant progression
Neuro-Oncology Advances·2023· 33 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

A. Hartley(19), Hisham Mehanna(10), J. Glaholm(7), Vijay Sawlani(5), Helen Benghiat(5), Anthony Kong(5), Charles Fong(5), G. Cruickshank(4), Markand Patel(4), Catherine McBain(4), Christopher C. McConkey(3), Martin J. van den Bent(3), Marica Eoli(3), Juan Manuel Sepúlveda-Sánchez(3), Annemiek Walenkamp(3), Olivier Chinot(3), Filip De Vos(3), Nicolas Whenham(3), Michael Weller(3), Jim Looman(3)